What is Singleron Biotechnologies?
Singleron Biotechnologies is a pioneering entity in the field of single-cell sequencing, providing an integrated suite of products that encompass kits, advanced instrumentation, and sophisticated bioinformatics tools. Their proprietary technology empowers clinical researchers to derive critical insights from complex disease mechanisms, translating them into actionable medical guidance. Serving a global network of research institutions and pharmaceutical firms, Singleron is dedicated to advancing precision medicine through high-quality data generation and interpretation, with a notable track record in oncology, immunology, and neuroscience applications.
How much funding has Singleron Biotechnologies raised?
Singleron Biotechnologies has raised a total of $30M across 1 funding round:
Other Financing Round
$30M
Other Financing Round (2020): $30M, investors not publicly disclosed
What's next for Singleron Biotechnologies?
The substantial enterprise-level funding and recent strategic investment signal a pivotal phase for Singleron Biotechnologies. This capital infusion is anticipated to accelerate the company's research and development initiatives, expand its global market reach, and enhance its product offerings in single-cell analysis. Strategic partnerships and further technological advancements are expected as the company solidifies its role in driving precision medicine forward.
See full Singleron Biotechnologies company page
